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the Forefoot of Individuals
with Diabetes and a
Prior Plantar Ulcer
BY DOUGLAS D. ROBERTSON, MD, PHD, MICHAEL J. MUELLER, KIRK E. SMITH, PAUL K. COMMEAN,
THOMAS PILGRAM, PHD, AND JEFFREY E. JOHNSON, MD
Investigation performed at Washington University School of Medicine, St. Louis, Missouri

Background: Plantar ulcers produced by diabetic foot disease are devastating and costly. Better understanding
of the ulcer-producing process is important to improve detection of feet that are at risk and to improve intervention. We identified and quantified soft-tissue and osseous structural changes in the forefoot of diabetic patients with a prior plantar ulcer.
Methods: Thirty-two individuals with a mean age (and standard deviation) of 57 ± 11 years were studied; sixteen had diabetes (of a mean of 20 ± 11 years’ duration), peripheral neuropathy, and a prior plantar ulcer, and
sixteen were matched controls. Computed tomography was used to evaluate forefoot structure, including the
plantar soft-tissue (muscle) density, soft-tissue thickness beneath the metatarsal heads, metatarsophalangeal
joint angle, metatarsal bone density, and metatarsophalangeal joint arthropathy.
Results: Plantar soft-tissue (muscle) density was lower in the individuals with diabetes (mean, 1 HU [Hounsfield unit]) than it was in the controls (mean, 18 HU). There was no difference in the soft-tissue thickness beneath the metatarsal heads (mean, 10 mm) between the individuals with diabetes and the controls, but the
soft-tissue thickness decreased with age. The individuals with diabetes had greater extension deformity of the
first, second, and third metatarsophalangeal joints and greater arthropathy of the second, third, and fourth
metatarsophalangeal joints. There were no significant differences in metatarsal bone density between the
groups.
Conclusions: There were significant differences between the forefeet of individuals with diabetes and a previous plantar ulcer and those of controls: plantar muscle density was decreased, and metatarsophalangeal joint
extension and arthropathy were increased. Interestingly, the soft-tissue thickness under the metatarsal heads
in the controls was not greater than that in the diabetic patients.
Clinical Relevance: This study demonstrated structural differences between the forefeet of patients with diabetes and a previous ulcer and those of normal age-matched controls. The information can serve to guide new interventions to prevent or treat foot ulcerations in this patient population.

A

s a result of medical advances, patients with diabetes
now lead healthier and longer lives1,2. However, foot ulceration, a common complication of diabetes, is a devastating and costly event that frequently recurs1,3-10. Foot ulcers
are the most frequent cause of hospitalization of patients with
diabetes and the most common reason for lower-extremity
amputation in the United States1,4,5,11-13. Worse, the rates of
diabetes-related amputation are increasing1.
Diabetes-associated neuropathy, peripheral vascular disease, and infection all contribute to the process that produces
ulceration and diabetic foot disease12,14-20. Altered mechanical
forces, especially high plantar pressures, are also an important

factor15-17,21-25. Although a specific ulcer-producing pressure
threshold has not been identified and appears to vary according to patient-related characteristics, reduction of high plantar
pressure in feet that have lost protective sensation is the
cornerstone of current prevention and treatment15,17,19,20,22,26,27.
While current accommodative or protective treatments are
useful, their success is limited, as evidenced by rates of ulcer
recurrence of approximately 35% at one year and 70% at five
years7-9. A reduction in the rate of plantar ulceration and its
sequelae would improve the quality of many lives and provide
considerable medical cost savings.
Peak plantar pressures occur in the forefoot, at the site of
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TABLE I Demographics and Attributes
Age* (yr)

Gender

Race

Foot

Individuals with diabetes

56 ± 10 (40-80)

5F, 11M

2B, 14W

9R, 7L

Controls

57 ± 11 (40-73)

6F, 10M

2B, 14W

7R, 9L

P value

0.78#

0.71**

1.00**

0.48**

*The values are given as the mean and standard deviation, with the range in parentheses. †Overweight has been defined as a body-mass
index of ≥25 kg/m2 and obesity, as an index of ≥30 kg/m2 or more72. ‡NA = not applicable. §The duration of diabetes indicates the number
of years following the original diagnosis of diabetes. #Two-tailed independent-samples t test. **Chi-square test.

skin breakdown, in individuals in whom ulcers develop16,22-24.
However, few studies have detailed the structural changes in the
forefoot that produce high pressures and result in ulceration in
feet with reduced sensation22,28. Architectural changes such as
hammer toe are a frequent finding and have been postulated to
increase the risk of ulceration23,29,30. Changes in material properties produced by tissue glycosylation and reparative new tissue have also been postulated to increase the likelihood of
ulceration23,31-33. However, little is actually known about how
these factors are related to the production of foot ulcers.
Improved knowledge of the structure of feet at risk
should assist in both prevention and treatment. Most investigators have used radiography to study the structure of the foot in
diabetic patients; ultrasound has been used only recently29,30,34-38.
The limitations of planar studies (radiography and ultrasound)
are that they do not allow a unified structural assessment.
Computed tomography, an accurate and reproducible
imaging method, displays three-dimensional musculoskeletal
structure39-42. Internal and external soft tissue, osseous geometry, material properties (tissue density), and arthropathy can
be evaluated and quantified39-47. In addition, computed tomography reveals interrelationships between different structures
and tissue types39-42,46. Also, computed tomography structural
analyses can be coupled with mechanical analyses, such as
measurements of plantar pressure42,48. Thus, computed tomography is useful for exploring the relationship between foot
structure and function and elucidating methods to improve
the prevention and treatment of foot disease.
The purpose of this study was to use computed tomography to identify, quantify, and elucidate relationships among
structural changes of the forefoot in diabetic individuals with
a prior plantar ulcer and in matched controls. We expected
diabetes-related muscle-wasting and tissue-stiffening to produce changes in plantar muscle density and soft-tissue thickness, metatarsophalangeal joint extension, metatarsophalangeal
arthropathy, and metatarsal bone density.
Materials and Methods
hirty-two subjects were studied. Each gave informed consent and was studied according to a protocol approved by
an institutional review board. Sixteen subjects who had been diagnosed as having diabetes with peripheral neuropathy (loss of
protective sensation [5.07 on the Semmes-Weinstein mono-

T

filament test]) and a prior neuropathic plantar ulcer were recruited from a multidisciplinary tertiary-care diabetes clinic. At
the time of the study, thirteen of these patients were receiving
insulin therapy, and three were receiving oral hypoglycemic
medications. The types of diabetes, duration of the diabetes
since the diagnosis, and hemoglobin A1c values are summarized in Table I. The anatomical distribution of the prior ulcers,
which had all healed (grade 0, according to Wagner’s system49),
is illustrated in Figure 1. Ten patients had had a single ulcer, five
had had ulcers at two sites, and one had had ulcers at three sites.
The foot with the prior ulcer or ulcers was studied. When both

Fig. 1

Location and frequency of prior plantar ulcers in the individuals with diabetes. Ten patients had a single ulcer, five had ulcers at two sites,
and one had ulcers at three sites.
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TABLE I (continued)
Height*
(cm)

Weight*
(kg)

Body-Mass
Index*† (kg/m2)

Type of
Diabetes‡

Duration of
Diabetes*‡§ (yr)

Hemoglobin
A1c*‡ (%)

179 ± 10 (155-201)

104 ± 25 (72-161)

33 ± 8 (24-47)

5 I, 11 II

20 ± 11 (2-40)

7.6 ± 1 (5-10)

175 ± 12 (156-194)

100 ± 36 (72-199)

32 ± 9 (23-55)

NA

NA

NA

0.33#

0.74#

0.89#

feet had had one or more prior ulcers, the foot that the subject
judged to have caused the most problems was studied, except
when the subject had had a partial foot resection. Sixteen
healthy control subjects were matched to the diabetic group by
age, gender, race, foot studied (right or left), height, weight, and
body-mass index (the individual’s weight [in kilograms] divided by the square of his or her height [in square meters]).
Individuals were excluded if they were unable to walk independently, were women of childbearing age, or had inflammatory
arthritis.
Computed tomography scanning was performed with
the subject sitting, on a specially constructed chair on top of
the scanner table, with the leg extended and the foot pressed
flat against a fixed vertical force-plate42,48. Subjects were asked
to relax and to not push against the force-plate. A digital readout, visible to the subjects, assisted them in maintaining the
“no-load” condition (defined as <4.5 kg). The spiral computed
tomography scanning (Somatom Plus 4; Siemens, Iselin, New
Jersey) was performed with 3-mm collimation, 3-mm table increment, 120-kVp, and 220 mÅ. The foot was imaged from
the plantar surface to the ankle with scan times of approximately thirty seconds.
Image slices, 1-mm thick, were reconstructed and were
transferred to an image-processing workstation. The original
volumetric computed tomography data set was resized to isotropic voxels with use of trilinear interpolation (AnalyzePC;
Biomedical Imaging Resource, Rochester, Minnesota). All
analyses used the resized volumetric data set. Isotropic voxel
dimensions ranged from 0.4 to 0.6 mm per side. All image reformations and image analyses were performed with use of
AnalyzePC.
Plantar Soft-Tissue (Muscle) Density
at the Midparts of the Metatarsal Shafts
Measurements of plantar soft-tissue (muscle) density (a material property) quantified the structural change produced by
diabetes-related atrophy of the intrinsic plantar muscles. In
some diabetic individuals, it was difficult to delineate the outlines of the intrinsic muscles because of atrophy and infiltration. For this reason, we outlined the plantar soft tissue
superficial to the metatarsals and deep to the dermis as a surrogate measurement of the plantar muscles. Although this
soft-tissue region consisted mostly of plantar muscle, it also

contained fat and tendon. Axial computed tomography images (perpendicular to the long axis of the metatarsal) through
the midpart of each metatarsal shaft were produced by reformatting the volumetric computed-tomography data set. The
soft tissue (excluding dermis) plantar to each metatarsal was
manually outlined on the computed tomography image. The
mean number (and standard deviation) of Hounsfield units
(HU) was calculated from the pixels within the outlined
region on the computed tomography scan. Hounsfield
units, which are directly related to mass density43-45, range
from –1000 (air) to 3095 (metal), with water being 0. Typical values for fat, muscle, cancellous bone, and cortical bone
are –40, 20, 200, and 1000 HU, respectively50,51.
Soft-Tissue Thickness
Beneath the Metatarsal Heads
The thickness of the plantar soft tissue at the level of each
metatarsal head was measured on lateral-view maximumintensity projections of each ray. The distance (perpendicular
to the sole of the foot and the force-plate) from the most plantar bone at the head (or sesamoid) to the inner surface of the
skin defined the plantar soft-tissue thickness. This measurement quantified architectural change at the most common site
of plantar ulcers.
Metatarsophalangeal Joint Angle
Three-dimensional maximum-intensity projections of lateral
views of each ray were constructed for each foot, and the midpoints of the metatarsophalangeal joint, tarsometatarsal joint,
and proximal interphalangeal joint were identified on each of
these projections. Joining the midpoints of the appropriate
joints created metatarsal and proximal phalangeal lines. For
each ray, the metatarsophalangeal joint angle was defined by
subtracting from 180 the angle formed by the intersection of
the metatarsal and proximal phalangeal lines. Positive angles
represented extension of the joint. The angle of the proximal
interphalangeal joint was not measured; thus, extension deformities may represent hammer or claw toes. The metatarsophalangeal joint angle also does not differentiate static from
dynamic toe deformities.
Bone Density of the Metatarsal Heads
Sagittal computed-tomography images of each metatarsal
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were reformatted from the volumetric computed-tomography
data set. These images bisected the metatarsal along its long
axis and were used to measure the bone density of the metatarsal head. The periosteal contour around each metatarsal
head was outlined manually, and the mean number of Hounsfield units (and standard deviation) was calculated from the
pixel values within the outlined region of the metatarsal head
on the scan52,53.
Bone Density of the Midparts
of the Metatarsal Shafts
Axial computed-tomography sections of the midpart of each
metatarsal shaft were used to measure bone density. The periosteal and endosteal contours of each metatarsal cross-section
were manually outlined, and the mean number of Hounsfield
units (and standard deviation) of the metatarsal cortical bone
was calculated from the pixel values within the outlined region on the scan52,53.
Metatarsophalangeal Arthropathy
To better describe the condition of the metatarsophalangeal joint,
we developed an arthropathy rating based on joint subluxation,
loss of cartilage space, the presence of osteophytes, and lysis of the
metatarsal head. Three-dimensional maximum-intensity projections of the foot and multiple multiplanar images (sagittal, coronal,
and axial) of the metatarsophalangeal joints were reformatted from
the volumetric computed tomography volume. Subluxation was
graded on a 3-point scale, with 3 points given for 67% to 100%
coverage, 2 points for 34% to 66% coverage, and 1 point for 0 to
33% coverage. Three-point scales were also used to grade loss of
cartilage space (3 points when ≥50% of the normal space was
present, 2 points when 1% to 49% was present, and 1 point when
no space was present), to grade osteophytes (3 points for no or
small osteophytes, 2 points for moderate osteophytes, and 1 point
for large osteophytes), and to grade lysis of the metatarsal head (3
points when ≥75% of the head circumference was present, 2 points
when 50% to 74% was present, and 1 point when 0% to 49% was
present) (Fig. 2). The maximum score for each joint was 12 points,
which indicated that it was generally normal. The maximum score
for the sum of all five joints was 60 points. All feet were rated by a
consensus score of two observers who were blinded to the subject
group from which the images were derived.

S T R U C T U R A L C H A N G E S I N T H E F O RE F O O T O F I N D I V I D U A L S
W IT H D I A B E TE S A N D A PR I OR P L A NT A R ULCER

Statistical Analysis
Two-tailed independent-samples t tests were used to test for
differences, between individuals with diabetes and controls,
with respect to age, height, weight, body-mass index, soft-tissue
density, soft-tissue thickness, bone density of the midparts of
the metatarsal shafts, and bone density of the metatarsal
heads. Chi-square tests of independence were used to test
for differences, between individuals with diabetes and controls, with respect to gender, race, and foot studied (right
or left). The Wilcoxon signed-rank test was used to evaluate differences, between individuals with diabetes and controls, with respect to metatarsophalangeal arthropathy ratings
and metatarsophalangeal joint angles. In addition, associations between variables were analyzed with correlation analysis. Pearson correlation was used for data derived from
measurements, and Spearman rank-order correlation was
used for ranked data. All statistical testing was performed with
use of JMP software (SAS Institute, Cary, North Carolina),
with the level of significance set at p ≤ 0.05.
Reliability, Repeatability, and
Interobserver Variation of Measurements
To test reliability and repeatability, original and repeat measurements of plantar soft-tissue density, soft-tissue thickness beneath the metatarsal heads, bone density of the midparts of the
metatarsal shafts, and bone density of the metatarsal heads were
made by one observer for the first sixteen feet. Reliability (precision) was defined as the mean difference between repeated measurements of the same feet. Repeatability was the measure of
reliability relative to the variation among specimens.
Since the metatarsophalangeal arthropathy rating was
semiquantitative, it was based on the measurements made by
two observers. In addition to assigning a consensus rating to
each foot, both observers independently reevaluated each foot
at least eight weeks after assigning the first rating. The independent ratings were compared with each other and with the
consensus rating. The scores for the arthropathy characteristics (subluxation, loss of cartilage space, osteophytes, and lysis) were summed for each metatarsophalangeal joint,
producing 80 data points for analysis (sixteen subjects, with
five joints per subject). Calculation of the percentage of identical scores and Spearman rank-order correlation were used to

Fig. 2

Metatarsophalangeal joint arthropathy. Sagittal computed tomography reformations through the second metatarsal of a control subject with no arthropathy (left) and an individual with diabetes (right). Note the extended and subluxated metatarsophalangeal joint and lysis of the metatarsal
head in the diabetic foot.
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TABLE II Correlation Coefficients (R) and P Values* Derived from Linear Regression Analyses of Selected Parameters
for the Control Subjects

Subjects

Metatarsophalangeal
Joint Angle

Plantar
Soft-Tissue
(Muscle) Density

Soft-Tissue
Thickness Beneath
Metatarsal Heads

Bone Density
of Metatarsal
Heads

Age

Body-Mass
Index

Metatarsophalangeal
arthropathy rating

–0.41
0.11

0.16
0.54

–0.35
0.19

–0.11
0.69

–0.29
0.27

–0.26
0.33

–0.15
0.59

–0.24
0.37

0.22
0.42

0.64
0.01

–0.02
0.95

–0.12
0.67

0.49
0.06

–0.09
0.74

–0.67
0.004

0.26
0.33

–0.53
0.04

0.06
0.83

0.02
0.95

–0.37
0.16

Metatarsophalangeal
joint angle
Plantar soft-tissue
(muscle) density
Soft-tissue thickness
beneath metatarsal
heads
Bone density of
metatarsal heads
Age

–0.07
0.81

*The correlation coefficients (r) are on top, and the p values are underneath.

evaluate reliability of the arthropathy ratings.
Results
Plantar Soft-Tissue (Muscle) Density
Beneath the Midparts of the Metatarsal Shafts
he mean density (and standard deviation) of the plantar
soft tissue (muscle) under the midpoint of the metatarsals
was 18 ± 18 HU (range, –30 to 43 HU) in the control subjects
and 1 ± 12 HU (range, –22 to 18 HU) in the individuals with
diabetes (Fig. 3). The densities of the two groups were significantly different (two-tailed independent-samples t test, p =
0.004).
The plantar soft-tissue (muscle) density was inversely related to the body-mass index in the control group (r = −0.67, p =
0.004) and the pooled subject group (r = –0.40, p = 0.03) (Tables
II and III). The plantar soft-tissue (muscle) density was directly
related to the bone density of the metatarsal heads in the group
with diabetes (r = 0.60, p = 0.01) and the pooled subject group
(r = 0.55, p = 0.001) (Tables III and IV).

T

Soft-Tissue Thickness Beneath
the Metatarsal Heads
The mean thickness (and standard deviation) of the plantar soft
tissues under the metatarsal heads was 10 ± 2 mm (range, 7 to
13 mm) in the control subjects and 10 ± 1 mm (range, 7 to 12
mm) in the individuals with diabetes. There was no difference
between the two groups (two-tailed independent-samples t test,
p = 0.62). The soft-tissue thickness was inversely related to
age in the control group (r = –0.53, p = 0.04) and in the
pooled data (r = –0.47, p = 0.006) (Tables II and III).
Metatarsophalangeal Joint Angle
The metatarsophalangeal joint angles were all positive (i.e., in

extension). The angles of the first, second, and third toes of
the individuals with diabetes were greater than those of the
control subjects; the differences ranged from 32% to 170%
(Table V). These differences were significant for the first and
third toes but not for the second toe.
In the control subjects, the metatarsophalangeal joint angle
was directly related to age (r = 0.64, p = 0.01) (Table II). In the individuals with diabetes, the metatarsophalangeal joint angle was
directly related to the body-mass index (r = 0.56, p = 0.03) and inversely related to the plantar soft-tissue density (r = –0.46, which

Fig. 3

Plantar soft-tissue density beneath the midparts of the metatarsal
shafts. A control foot is at the top, and a diabetic foot is on the bottom.
Note the lower attenuation within the plantar tissues and the indistinctness of the plantar muscles of the diabetic foot.
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TABLE III Correlation Coefficients (R) and P Values* Derived from Linear Regression Analyses of Selected Parameters for the
Pooled Data on the Control Subjects and the Individuals with Diabetes

Metatarsophalangeal
arthropathy rating

Metatarsophalangeal
Joint Angle

Plantar
Soft-Tissue
(Muscle) Density

Soft-Tissue
Thickness Beneath
Metatarsal Heads

Bone Density
of Metatarsal
Heads

Age

Body-Mass
Index

–0.72
<0.001

0.51
0.003

–0.11
0.53

0.32
0.08

–0.20
0.28

–0.16
0.37

0.05
0.79

–0.08
0.66

0.33
0.06

0.31
0.09

0.55
0.001

–0.05
0.77

–0.40
0.03

0.11
0.55

–0.47
0.006

–0.01
0.96

–0.26
0.16

–0.17
0.34

Metatarsophalangeal
joint angle

–0.41
0.02

Plantar soft-tissue
(muscle) density

–0.09
0.62

Soft-tissue thickness
beneath metatarsal
heads
Bone density of
metatarsal heads
Age

0.03
0.89

*The correlation coefficients (r) are on top, and the p values are underneath.

approached significance with p = 0.07) (Table IV). For the pooled
data, the metatarsophalangeal joint angle was inversely related to
the plantar soft-tissue density (r = –0.41, p = 0.02) (Table III).
Bone Density of the Metatarsal Heads
The mean bone density (and standard deviation) of the metatarsal heads was 301 ± 51 HU (range, 204 to 419 HU) in the
control subjects and 272 ± 64 HU (range, 163 to 365 HU) in the
individuals with diabetes. There was no difference between the
two groups (two-tailed independent-samples t test, p = 0.16).
The bone density of the metatarsal heads was inversely

related to the age of the individuals with diabetes (r = –0.54,
p = 0.03) but not to that of the control subjects or in the
pooled data (Tables II, III, and IV). As noted, the plantar softtissue (muscle) density was directly related to the bone density
of the metatarsal heads in the individuals with diabetes and in
the pooled data (Tables III and IV). In the control subjects,
this relationship approached significance (Table II).
Bone Density of the Midparts
of the Metatarsal Shafts
The mean bone density (and standard deviation) of the mid-

TABLE IV Correlation Coefficients (R) and P Values* Derived from Linear Regression Analyses of Selected Parameters for the
Pooled Data on the Control Subjects and the Individuals with Diabetes

Metatarsophalangeal
arthropathy rating
Metatarsophalangeal
joint angle
Plantar soft-tissue
(muscle) density

Metatarsophalangeal
Joint Angle

Plantar
Soft-Tissue
(Muscle) Density

Soft-Tissue
Thickness Beneath
Metatarsal Heads

Bone Density
of Metatarsal
Heads

Age

Body-Mass
Index

–0.72
<0.001

0.51
0.003

–0.11
0.53

0.32
0.08

–0.20
0.28

–0.16
0.37

0.05
0.79

–0.08
0.66

0.33
0.06

0.31
0.09

0.55
0.001

–0.05
0.77

–0.40
0.03

0.11
0.55

–0.47
0.006

–0.01
0.96

–0.26
0.16

–0.17
0.34

–0.41
0.02

–0.09
0.62

Soft-tissue thickness
beneath metatarsal
heads
Bone density of
metatarsal heads
Age

*The correlation coefficients (r) are on top, and the p values are underneath.

0.03
0.089
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TABLE V Metatarsophalangeal Joint Angles
Metatarsophalangeal
Joint

Control
Subjects*

Individuals
with Diabetes*

P Value†

1st

10 ± 5 (4-19)

27 ± 21 (6-71)

0.004

2nd

38 ± 12 (15-57)

50 ± 21 (20-88)

0.064

3rd

33 ± 12 (16-55)

45 ± 16 (22-83)

0.029

4th

28 ± 12 (8-52)

35 ± 16 (12-77)

0.179

5th

24 ± 10 (9-44)

28 ± 14 (9-62)

0.368

*The values are given, in degrees, as the mean and standard deviation, with the range in parentheses. Positive values indicate extension.
†Significant differences according to the Wilcoxon signed-rank test are in bold.

parts of the metatarsal shafts was 754 ± 138 HU (range, 509 to
966 HU) in the control subjects and 716 ± 148 HU (range, 506
to 997 HU) in the individuals with diabetes. There was no difference between the two groups (two-tailed independentsamples t test, p = 0.46).
Metatarsophalangeal Arthropathy
Significant differences between the individuals with diabetes
and the control subjects were found for the ratings of the second, third, and fourth joints (Table VI).
The individuals with diabetes had greater variability
among the ratings for the metatarsophalangeal joints, with
standard deviations ranging from 2.0 to 2.7 for the first
through fourth toes, than did the control subjects, who had
standard deviations ranging from 0.3 to 0.6 for the second,
third, and fourth toes (Table VI). In the control group, the
variability (standard deviation) among the ratings for the first
toe was 1.0 compared with 2.7 in the group with diabetes. The
ratings for the fifth toe had low variability in both groups (Table VI).
In the group with diabetes (Table IV), the metatarsophalangeal arthropathy rating was inversely related to the
metatarsophalangeal joint angle (r = –0.73, p = 0.001) and directly related to the soft-tissue density (r = 0.58, p = 0.02).

These relationships were found in the pooled subject data (Table III), but not in the control subjects when that group was
analyzed alone (Table II).
Reliability, Repeatability, and
Interobserver Variation of Measurements
All objective measurements were highly reliable. The original
and repeat measurements averaged 33° ± 18° and 33° ± 18° for
the metatarsophalangeal joint angles, 12 ± 18 and 12 ± 18 HU
for the plantar soft-tissue (muscle) density, 10 ± 2 and 10 ± 2
mm for the soft-tissue thickness, and 292 ± 96 and 291 ± 72
HU for the bone density of the metatarsal heads. The repeatability of the measurements was high, with the variation between the original and repeat measurements representing
<1.0% (range, <0.1 to 0.6%) of the measurement variation
among the feet.
The mean difference (and standard deviation) between
the two observers with regard to their rating of the metatarsophalangeal arthropathy was 1.3 ± 1.8 of a possible 60 points
per subject. The independent ratings of the two observers
agreed with each other 66% of the time, and they agreed with
the initial consensus rating 61% and 54% of the time. The
Spearman rank-order correlation coefficients were 0.91 for
the repeat ratings of the two observers, 0.80 for the original

TABLE VI Metatarsophalangeal Arthropathy Ratings
Metatarsophalangeal
Joint

Control
Subjects*

Individuals with
Diabetes*

P Value†

1st

11.5 ± 1.0 (8-12)

10.0 ± 2.7 (5-12)

0.179

2nd

11.8 ± 0.5 (10-12)

9.7 ± 2.6 (5-12)

0.011

3rd

11.9 ± 0.3 (11-12)

10.5 ± 2.0 (7-12)

0.013

4th

11.8 ± 0.6 (10-12)

10.1 ± 2.1 (5-12)

0.003

5th

11.7 ± 0.5 (11-12)

11.25 ± 0.9 (10-12)

0.212

All

58.6 ± 2.5 (51-60)

51.5 ± 7.8 (35-60)

<0.001

*The values are given, in points, as the mean and standard deviation, with the range in parentheses. The maximum score for each joint was
12 points, which indicates an essentially normal joint. The maximum score for all five joints was 60 points. †Significant differences according to the Wilcoxon signed-rank test are in bold.
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consensus ratings and the first observer’s repeat ratings, and
0.74 for the original consensus ratings and the second observer’s repeat ratings.
Discussion
omputed tomography is an accurate, reliable, and reproducible tool for studying the musculoskeletal system39-42,46.
It has been used to aid in the diagnosis of infection in diabetic
patients6,54-56, but it has not been used to quantify and understand the structure of the diabetic forefoot. We utilized computed tomography instead of magnetic resonance imaging
because computed tomography provides more accurate measurements of bone morphology and density, creates higherspatial-resolution volumetric information, allows subjects to
sit during scanning, and permits use of the force-plate and
electronics without special adaptation.
While the cause of diabetic ulceration is multifactorial,
soft-tissue change (secondary to neuropathy and tissue glycosylation) is a key factor in the process. We found that plantar
soft-tissue (muscle) density was significantly lower in the individuals with diabetes. Although edematous changes could have
played a role, the reduction in density was most likely due to
fatty infiltration and replacement of the muscle. This hypothesis is supported by recent work demonstrating fatty infiltration
and replacement in diabetic and denervated muscle57-59.
The plantar soft-tissue (muscle) density in the control
subjects was inversely related to the body-mass index. Thus,
obese control subjects had less dense plantar soft tissue (muscle). We again postulated that this was due to fatty infiltration
and replacement of the muscle60-62. This relationship between
plantar soft-tissue (muscle) density and body-mass index was
not found in the individuals with diabetes, probably because
of the overriding influence of diabetes-associated peripheral
neuropathy. In other words, while obesity results in morbid
changes in the forefoot, the influence of diabetes is greater. Interestingly, the plantar soft-tissue (muscle) density was related to the bone density of the metatarsal heads. This
probably was a reflection of the general status of the foot
that is, healthy feet had good muscle and bone densities and
diseased feet did not.
Despite widely held opinion, we found no difference between the individuals with diabetes and the control subjects
with regard to the thickness (an architectural property) of the
soft tissue under the metatarsal heads. The soft-tissue thickness was inversely related to agei.e., older subjects had thinner tissue. Thinning of soft tissue may have a role in the
development of metatarsalgia or discomfort beneath the
metatarsal heads in older individuals. It may also contribute to
production of ulcers in elderly individuals with diabetes.
The magnitudes of our thickness measurements were
similar to those in a recent study in which ultrasound was
used to measure plantar tissue thickness in four individuals
with diabetes (mean age, sixty-three years; mean duration of
the diabetes, twelve years)37. In that study, the feet of four
young healthy individuals (mean age, twenty-two years) were
studied for comparison. The tissue thickness in the controls
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was approximately twice that in the individuals with diabetes.
This finding could be explained by our observation that plantar soft-tissue thickness under the metatarsal heads decreases
with age.
Osseous changes are also key factors in the multifactorial process of ulceration. Extension of the metatarsophalangeal joint (an architectural property) unloads the toe and
increases weight-bearing pressure on the metatarsal heads28,63.
Intrinsic muscle atrophy can produce extension of the metatarsophalangeal joint64,65. In this study, extension of the metatarsophalangeal joint was more prevalent among the individuals
with diabetes, probably as a result of muscle-wasting produced by diabetes-associated neuropathy. This finding corroborates those of previous studies in which hammer toe was
found to be a risk factor for ulceration23,29,30.
To complete the analysis of forefoot structure, we studied the bone density of the metatarsal heads and metatarsophalangeal arthropathy. Interestingly, we found no difference
in the bone density of the metatarsal heads between the individuals with diabetes and the control subjects. However, as
noted previously, the bone density of the metatarsal heads
was directly related to plantar soft-tissue (muscle) density.
To provide an internal control, we also measured the bone
(cortical) density of the midparts of the metatarsal shafts. No
difference was found between the individuals with diabetes
and the control subjects. Our bone density values were in
agreement with the measurements of metatarsal density reported by others66-68.
In order to better describe the metatarsophalangeal
joint, we developed an arthropathy rating based on subluxation, loss of cartilage space, lysis of the metatarsal heads, and
osteophytes. While there are other characteristics of arthropathy30,35, we wanted to keep the system simple, reliable, and
capable of distinguishing individuals with diabetes from
control subjects. As tested, the rating system was reliable and
reproducible. With use of the arthropathy rating system, we
were able to detect differences, between the metatarsophalangeal joints of individuals with diabetes and those of the
control subjects, not accounted for by joint extension angles
alone.
Individuals with diabetes had more arthropathy than
controls, especially in the second, third, and fourth toes. As
with other measurements in this study, variability among the
individuals with diabetes was higher than that among the control subjects. The first toe was an exception: the measurements
at this site varied moderately among the control subjects,
which contributed to the lack of a significant difference between the groups with regard to these measurements. The
variability of the ratings for the first toes of the control subjects was due to the prevalence of osteoarthritis, which is not
surprising since the first toe is the primary site of osteoarthritis in the forefoot69-71.
In the individuals with diabetes, an increase in metatarsophalangeal arthropathy was related to an increase in the
metatarsophalangeal joint angle and a decrease in the plantar soft-tissue (muscle) density. This patterned data influ-
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enced the pooled data but was not present in the control
group. We postulated that increased diabetic effects (worse
hammer-toe deformity and plantar muscle density) directly
or indirectly cause (through altered weight-bearing) worse
arthropathy.
Two general concepts stood out in this study. One was
that there was more variability among individuals with diabetes than there was among control subjects. The other was that
diabetes-associated morbidities were dominant. Aging and
obesity caused forefoot comorbidities, but their effects were
overridden by those of the diabetes. Both of these concepts
demonstrate the complexity of understanding, modeling, and
treating the diabetic foot.
In conclusion, computed tomography was an effective
tool for demonstrating variations between the forefeet of individuals with diabetes and a previous plantar ulcer and those of
normal age-matched controls. By linking architectural and
material properties (density) of both soft and osseous tissue,
our study provided information that can guide new interventions for prevention or treatment of foot ulcers in individuals
with diabetes. 
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